Jean‐Philippe Spano

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

Joe‐Elie Salem, Ali Manouchehri, Melissa Moey et al. · The Lancet Oncology · 2018 · 1.1K citations

Inflammation, Cardiovascular Toxicity, Immunotoxicology +12

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Impact of EGFR expression on colorectal cancer patient prognosis and survival

Jean‐Philippe Spano, Christine Lagorce, D Atlan et al. · Annals of Oncology · 2004 · 458 citations · Full text

Egfr Expression, Oncology, Medicine +8

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

Jean‐Yves Blay, Charles Honoré, Eberhard Stoeckle et al. · Annals of Oncology · 2019 · 307 citations · Full text

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · The Lancet · 2008 · 249 citations

Oncology, Pancreatic Cancer, Gastrointestinal Oncology +6